BG Medicine, Inc.
(Other OTC/NBB : BGMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.04%185.231.2%$602.93m
CELGCelgene Corporation
-0.79%78.181.2%$528.43m
GILDGilead Sciences, Inc.
-0.15%70.970.9%$517.90m
BIIBBiogen Inc.
-1.78%290.771.2%$429.53m
NKTRNektar Therapeutics
-2.44%51.565.6%$402.91m
SRPTSarepta Therapeutics, Inc.
-2.95%136.1916.6%$345.86m
VRTXVertex Pharmaceuticals Incorporated
-2.72%154.861.9%$261.95m
REGNRegeneron Pharmaceuticals, Inc.
-2.37%324.102.6%$242.13m
ILMNIllumina, Inc.
-2.47%275.673.5%$207.56m
BLUEBluebird Bio, Inc.
-4.59%161.1515.7%$185.38m
EXASExact Sciences Corporation
-3.08%64.2925.4%$175.41m
AAgilent Technologies, Inc.
-2.36%61.311.5%$174.23m
ALXNAlexion Pharmaceuticals, Inc.
-1.94%125.102.0%$156.83m
BMRNBioMarin Pharmaceutical Inc.
-3.96%95.114.4%$136.37m
INCYIncyte Corporation
-2.83%71.942.5%$129.52m

Company Profile

BG Medicine, Inc. engages in the research and development, clinical research, manufacture and sale of diagnostic products for heart failure and related disorders. It distributes its products such as BGM Galectin-3 to clinical laboratories, hospitals and health care provider. The company was founded in February 2000 and is headquartered in Waltham, MA.